Hendon Partners

Industry: Medicare Skilled Home Health

Medicare Skilled Home Health M&A Advisory.

Medicare-certified skilled home health agencies are among the most coveted assets in healthcare M&A. Hendon Partners delivers unmatched expertise and buyer access, helping owners achieve maximum value in competitive sell-side processes.

Contact Us

Market Overview

The Medicare Skilled Home Health M&A Landscape

4–8×
Typical EBITDA Multiple Range
High
Strategic Buyer Demand
Active
Private Equity Interest

Medicare-certified agencies offering skilled nursing, physical therapy, occupational therapy, and speech pathology services remain the highest-demand acquisition targets in home-based care. Key value drivers include census, payer mix, STAR ratings, geographic density, and operational margins.

Hendon Partners maintains active relationships with every major national and regional skilled home health acquirer, as well as leading PE platforms. We ensure clients receive competitive offers, not just the first one that arrives.

Why Hendon

What We Bring to Your Skilled Home Health Sale

Deep Buyer Relationships

We know every major skilled home health acquirer: what they pay, what they look for, and how to position your agency to maximize value.

Regulatory and Clinical Expertise

PDGM, OASIS, CoPs, STAR ratings. We understand how the clinical and regulatory landscape shapes buyer perception and final valuation.

Competitive Process Design

Our structured auction processes generate multiple simultaneous offers, driving price and improving deal terms through genuine competition.

Full Transaction Management

From valuation to funded close, we manage every step of the process so you can remain focused on patient care and operations.

Frequently Asked Questions

What is my Medicare home health agency worth?
+
Medicare-certified skilled home health agencies typically trade at 4–8× EBITDA. Value is driven by census, PDGM revenue performance, STAR ratings and quality scores, geographic density, Medicare Advantage exposure, and referral diversification.
How does PDGM affect home health agency valuations?
+
PDGM rewarded operationally sophisticated agencies and pressured weaker operators, creating a flight to quality. Buyers underwrite your case-mix management, LUPA rates, and therapy utilization closely — strong PDGM performance commands a premium.
Does Medicare Advantage penetration hurt my valuation?
+
Rising Medicare Advantage penetration compresses per-episode rates, so buyers scrutinize your MA versus traditional Medicare mix. Agencies that have adapted operationally to MA, or that hold strong MA contracts, defend their multiples better.
How long does it take to sell a home health agency?
+
With a represented, competitive process, most home health transactions move from engagement to funded close in roughly 60–120 days, versus 6–18 months for owners attempting to sell on their own.

Go Deeper

Home Health M&A Insights

Guides on PDGM, Medicare Advantage, and what drives skilled home health valuations.

Thinking About Selling Your Skilled Home Health Agency?

Start with a confidential conversation about your agency's market value and exit options. No obligation.

Contact Us